Pages
Products

LRP1


Official Full Name
LDL receptor related protein 1
Organism
Homo sapiens
Gene ID
4035
Background
This gene encodes a member of the low-density lipoprotein receptor family of proteins. The encoded preproprotein is proteolytically processed by furin to generate 515 kDa and 85 kDa subunits that form the mature receptor (PMID: 8546712). This receptor is involved in several cellular processes, including intracellular signaling, lipid homeostasis, and clearance of apoptotic cells. In addition, the encoded protein is necessary for the alpha 2-macroglobulin-mediated clearance of secreted amyloid precursor protein and beta-amyloid, the main component of amyloid plaques found in Alzheimer patients. Expression of this gene decreases with age and has been found to be lower than controls in brain tissue from Alzheimer's disease patients. [provided by RefSeq, Oct 2015]
Synonyms
APR; KPA; LRP; A2MR; CD91; DDH3; APOER; LRP1A; TGFBR5; IGFBP3R; IGFBP-3R; IGFBP3R1

Cat.No. Product Name Price
SHH241018 shRNA set against Mouse Arvcf (NM_033474.2) Inquiry
SHW005738 shRNA set against Chicken LRP1 (NM_205242) Inquiry
SHG075305 shRNA set against Mouse Arvcf(NM_033474.2) Inquiry
SHG118711 shRNA set against Mouse C1d(NM_020558.3) Inquiry
SHH160967 shRNA set against Human LRP1(NM_002332.2) Inquiry
SHH160985 shRNA set against Mouse Lrp1(NM_008512.2) Inquiry
SHH241014 shRNA set against Human Arvcf (NM_001670.2) Inquiry
SHH250274 shRNA set against Mouse C1D (NM_020558.3) Inquiry
SHH250278 shRNA set against Rat C1D (NM_001106021.1) Inquiry
SHH333947 shRNA set against Human LRP1 (NM_002332.2) Inquiry
SHH333951 shRNA set against Mouse LRP1 (NM_008512.2) Inquiry
SHW001658 shRNA set against Chicken C1D (NM_001031036) Inquiry
SHW003461 shRNA set against Chicken C1D (NM_001244737) Inquiry
SHW004978 shRNA set against Chicken ARVCF (NM_204465) Inquiry
SHW007515 shRNA set against Danio rerio C1D (NM_001007059) Inquiry
Cat.No. Product Name Price
MiUTR3H-08888 C1D miRNA 3'UTR clone Inquiry
MiUTR3H-04830 ARVCF miRNA 3'UTR clone Inquiry
MiUTR1M-06743 LRP1 miRNA 3'UTR clone Inquiry
CDCB167213 Chicken LRP1 ORF Clone (NM_205242) Inquiry
MiUTR1M-02349 C1D miRNA 3'UTR clone Inquiry
MiUTR1M-01721 ARVCF miRNA 3'UTR clone Inquiry
MiUTR1H-05896 LRP1 miRNA 3'UTR clone Inquiry
CDFR009395 Rat Arvcf cDNA Clone(NM_001131013.1) Inquiry
CDFR005795 Rat C1d cDNA Clone(NM_001106021.1) Inquiry
MiUTR3H-08887 C1D miRNA 3'UTR clone Inquiry
CDCS410749 Human LRP1 ORF Clone (BC045107) Inquiry
CDCS409195 Human C1D ORF Clone (BC005235) Inquiry
CDCS409194 Human C1D ORF Clone (BC009584) Inquiry
CDCR376830 Rat Arvcf ORF Clone(NM_001131013.1) Inquiry
CDCR280891 Human ARVCF ORF Clone(NM_001670.2) Inquiry
CDCR030622 Mouse Arvcf ORF clone (NM_033474.2) Inquiry
CDCL186418 Human TGF-beta 3 ORF clone(NM_003239.2) Inquiry
CDCL185194 Human LRP1 ORF clone(NM_002332.2) Inquiry
CDCH388042 Rat LRP1 ORF clone(NM_001130490.1) Inquiry
CDCH388041 Mouse LRP1 ORF clone(NM_008512.2) Inquiry
CDCB195474 Rabbit LRP1 ORF clone (XM_002720944.3) Inquiry
CDCB194787 Rabbit C1D ORF clone (XM_008254321.1) Inquiry
CDCB185598 Rabbit ARVCF ORF clone (XM_008250594.1) Inquiry
CDCB168990 Danio rerio C1D ORF Clone (NM_001007059) Inquiry
CDCB166453 Chicken ARVCF ORF Clone (NM_204465) Inquiry
CDCB164936 Chicken C1D ORF Clone (NM_001244737) Inquiry
CDCR372823 Rat C1d ORF Clone(NM_001106021.1) Inquiry
CDCB163133 Chicken C1D ORF Clone (NM_001031036) Inquiry

Detailed Information

Low-density lipoprotein receptor-related protein 1 (LRP1) was first discovered in 1988 through screening mouse lymphocyte and human liver cDNA libraries for sequences homologous to the apoE binding domain of the LDL receptor (LDLR). Compared to LDLR, LRP1 is a structurally massive type I transmembrane protein, encoding 4,525 amino acids and consisting of two subunits: a 515 kDa N-terminal extracellular subunit and an 85 kDa C-terminal transmembrane subunit, which are associated non-covalently. These two subunits are transported to the cell surface after being cleaved by furin enzyme in the trans-Golgi network.

Figure 1: Domain structure schematic of LRP1 and LDLR showing ligand binding domains, cysteine-rich repeats, furin cleavage site, β-propeller domain, and endocytic motifs (NPXY, YXXL) in the cytoplasmic tail. Figure 1. Schematic diagram of domain structure for LRP1 and LDLR. (Shinohara M, et al., 2017)

The extracellular region of LRP1 contains four cysteine-rich ligand-binding domains (I-IV), comprising 2, 8, 10, and 11 complement-type repeats, respectively. Domains II and IV are the primary binding sites for most ligands in the presence of calcium ions. Additionally, its cytoplasmic tail contains multiple NPXY motifs, which are critical signals for mediating endocytosis through clathrin-coated pits, and work in concert with adjacent YXXL and dileucine motifs to achieve rapid internalization. The EGF-like repeats and YWTD β-propeller domains in the extracellular region facilitate the dissociation of ligands in endocytic vesicles.

Effective transport of LRP1 to the cell surface depends on a 39 kDa molecular chaperone—Receptor-Associated Protein (RAP). RAP binds to LRP1 in the early secretory pathway, preventing premature binding with other ligands, and dissociates in the late, low pH environment. RAP, as a universal ligand for LRP1, can block the binding of almost all known LRP1 ligands.

To date, over 40 proteins have been identified as LRP1 ligands, including Aβ, apoE, and activated α2-macroglobulin. However, controversy exists regarding whether Aβ directly binds to domains II and IV of LRP1. While Deane et al. demonstrated in vitro that Aβ (particularly the monomeric form of Aβ40) can bind to these domains, Yamada et al. were unable to reproduce these results in similar experiments. Some studies suggest that LRP1 might depend on other Aβ-binding proteins (such as heparan sulfate proteoglycans) to jointly mediate Aβ internalization. The aggregated or oligomeric forms of Aβ have relatively weaker affinity for LRP1.

Notably, apoE's ability to bind to LRP1 is significantly influenced by its conformation and lipidation state.

Beyond ligand metabolism, LRP1 can also regulate cellular signaling pathways by forming complexes with membrane proteins such as platelet-derived growth factor receptor (PDGF) and N-methyl-D-aspartate receptor (NMDA receptor). Furthermore, LRP1 can be cleaved by β-secretase or α-secretase and γ-secretase, producing intracellular fragments that can act as transcriptional regulatory factors, modulating the expression of multiple genes including interferon-γ, with functions similar to amyloid precursor protein (APP). Simultaneously, the soluble form of LRP1 (sLRP1) also plays an important role in Aβ metabolism.

LRP1 is highly expressed in various tissues, including the liver, brain, and vascular system. Conventional LRP1 knockout mice exhibit early embryonic lethality, in stark contrast to the non-lethal phenotype of LDLR knockout mice. Animal experiments with conditional knockout in hepatocytes, macrophages, adipocytes, and vascular smooth muscle cells indicate that LRP1, by regulating ligand metabolism and signaling pathway intensity, is crucial for tissue development and homeostasis maintenance. Its dysfunction may be associated with diseases such as atherosclerosis and cancer.

Particularly in the nervous system, LRP1 is highly relevant to the pathogenesis of Alzheimer's disease. Animal studies suggest that LRP1 regulates Aβ metabolism and brain homeostasis through multiple pathways, which may depend on apoE subtypes or be independent of apoE. However, since most studies are based on cell or animal models, its specific role in AD remains uncertain. Future research needs to systematically examine: first, changes in LRP1 expression and function at different stages (especially preclinical) in human AD patients; second, the diverse functional roles LRP1 might play in different cell types, ages, disease stages, and apoE subtype backgrounds. These studies will help develop LRP1-targeted therapeutic strategies for AD.

References

  1. Shinohara M, Tachibana M, Kanekiyo T, et al. Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies. J Lipid Res. 2017 Jul;58(7):1267-1281.
  2. Jaeger S, Pietrzik CU. Functional role of lipoprotein receptors in Alzheimer's disease. Curr Alzheimer Res. 2008 Feb;5(1):15-25.
Quick Inquiry